141 related articles for article (PubMed ID: 2016727)
1. Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.
Cho H; Ueda M; Tamaoka M; Hamaguchi M; Aisaka K; Kiso Y; Inoue T; Ogino R; Tatsuoka T; Ishihara T
J Med Chem; 1991 Apr; 34(4):1503-5. PubMed ID: 2016727
[No Abstract] [Full Text] [Related]
2. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
[TBL] [Abstract][Full Text] [Related]
4. [Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties].
Mirzoeva OK; Sud'ina GF; Pushkareva MA; Korshunova GA; Sumbatian NV; Varfolomeev SD
Bioorg Khim; 1995 Feb; 21(2):143-51. PubMed ID: 7538294
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
6. Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties.
Sigal E; Grunberger D; Cashman JR; Craik CS; Caughey GH; Nadel JA
Biochem Biophys Res Commun; 1988 Jan; 150(1):376-83. PubMed ID: 3337718
[TBL] [Abstract][Full Text] [Related]
7. 5- and 15(omega-6)-lipoxygenases from human polymorphonuclear leukocytes.
Soberman RJ
Methods Enzymol; 1988; 163():344-9. PubMed ID: 3070300
[No Abstract] [Full Text] [Related]
8. Lipoxin formation: evaluation of the role and actions of leukotriene A4.
Serhan CN; Sheppard KA; Fiore S
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():54-62. PubMed ID: 2169183
[No Abstract] [Full Text] [Related]
9. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
10. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and molecular biological approaches to two types of arachidonate 12-lipoxygenase.
Yamamoto S; Yoshimoto T; Takahashi Y; Suzuki H; Arakawa T; Kishimoto K; Hada T; Oshima T; Murakami J; Yamamoto Y
J Lipid Mediat; 1993; 6(1-3):69-73. PubMed ID: 8358017
[No Abstract] [Full Text] [Related]
12. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase.
Sugiura M; Naito Y; Yamaura Y; Fukaya C; Yokoyama K
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1039-43. PubMed ID: 2766406
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of platelet lipoxygenase from Ponkan fruit.
Nogata Y; Sekiya K; Ohta H; Kusumoto K; Ishizu T
Phytochemistry; 2001 Apr; 56(7):729-32. PubMed ID: 11314960
[TBL] [Abstract][Full Text] [Related]
14. Effect of catechol derivatives on cell growth and lipoxygenase activity.
Simpson J; Forrester R; Tisdale MJ; Billington DC; Rathbone DL
Bioorg Med Chem Lett; 2003 Aug; 13(15):2435-9. PubMed ID: 12852938
[TBL] [Abstract][Full Text] [Related]
15. Effects of caffeoylglycosides on arachidonate metabolism in leukocytes.
Kimura Y; Okuda H; Nishibe S; Arichi S
Planta Med; 1987 Apr; 53(2):148-53. PubMed ID: 3110811
[No Abstract] [Full Text] [Related]
16. Caffeic acid is a selective inhibitor for leukotriene biosynthesis.
Koshihara Y; Neichi T; Murota S; Lao A; Fujimoto Y; Tatsuno T
Biochim Biophys Acta; 1984 Jan; 792(1):92-7. PubMed ID: 6318834
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and bioactivity of novel caffeic acid esters from Zuccagnia punctata.
Ramachandra MS; Subbaraju GV
J Asian Nat Prod Res; 2006 Dec; 8(8):683-8. PubMed ID: 17145655
[TBL] [Abstract][Full Text] [Related]
18. Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases.
Ueda N; Yamamoto K; Kurahashi Y; Yamamoto S; Ogawa M; Matsuki N; Kudo I; Shinkai H; Shirakawa E; Tokunaga T
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():163-5. PubMed ID: 7732825
[No Abstract] [Full Text] [Related]
19. Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.
Lazer ES; Wong HC; Wegner CD; Graham AG; Farina PR
J Med Chem; 1990 Jul; 33(7):1892-8. PubMed ID: 2113949
[TBL] [Abstract][Full Text] [Related]
20. Substituted Caffeic and Ferulic Acid Phenethyl Esters: Synthesis, Leukotrienes Biosynthesis Inhibition, and Cytotoxic Activity.
Morin P; St-Coeur PD; Doiron JA; Cormier M; Poitras JJ; Surette ME; Touaibia M
Molecules; 2017 Jul; 22(7):. PubMed ID: 28684707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]